ABIONYX Pharma financials at a glance

The revenue of ABIONYX Pharma is reported as 0.0046 billion Euro in the fiscal year 2023. The earnings were -0.14 Euro per share in 2023, which was 36.36 higher than 2022. And about -0.00421 billion Euro are reported as free cash flow in the financials of ABIONYX Pharma 2023. No dividends were paid to the shareholders of the ABIONYX Pharma stock ENXTPA:ABNX in the financial year 2023.